Partnership combines pharmaceutical-grade manufacturing with Ispire’s global platform to accelerate entry into one of the fastest-growing nicotine segments LOS ANGELES, May 12, 2026 /PRNewswire/ — Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR), a trailblazer in vaping…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
